[7-[(2-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-fluorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(4-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;bis([7-[(3-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone);[7-[(4-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;(4-methylpyrazol-1-yl)-[7-[(3-morpholin-4-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone;(4-methylpyrazol-1-yl)-[7-[(3-pyrrolidin-1-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone
C203H261Cl2FN42O13 — CID 159533540
Data last refreshed: (MolForge compound catalog, from PubChem)
About [7-[(2-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-fluorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(4-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;bis([7-[(3-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone);[7-[(4-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;(4-methylpyrazol-1-yl)-[7-[(3-morpholin-4-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone;(4-methylpyrazol-1-yl)-[7-[(3-pyrrolidin-1-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone
[7-[(2-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-fluorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(4-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;bis([7-[(3-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone);[7-[(4-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;(4-methylpyrazol-1-yl)-[7-[(3-morpholin-4-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone;(4-methylpyrazol-1-yl)-[7-[(3-pyrrolidin-1-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone (PubChem CID 159533540) has the molecular formula C203H261Cl2FN42O13 and a molecular weight of 3587.51 g/mol. Its IUPAC name is [7-[(2-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-fluorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(4-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;bis([7-[(3-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone);[7-[(4-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;(4-methylpyrazol-1-yl)-[7-[(3-morpholin-4-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone;(4-methylpyrazol-1-yl)-[7-[(3-pyrrolidin-1-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone.
Molecular Properties
| Compound Name | [7-[(2-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-fluorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(4-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;bis([7-[(3-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone);[7-[(4-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;(4-methylpyrazol-1-yl)-[7-[(3-morpholin-4-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone;(4-methylpyrazol-1-yl)-[7-[(3-pyrrolidin-1-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone |
|---|---|
| PubChem CID | 159533540 |
| Molecular Formula | C203H261Cl2FN42O13 |
| Molecular Weight | 3587.51 g/mol |
| Exact Mass | 3584.04 |
| IUPAC Name | [7-[(2-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-chlorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-fluorophenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(3-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;[7-[(4-methoxyphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;bis([7-[(3-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone);[7-[(4-methylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]-(4-methylpyrazol-1-yl)methanone;(4-methylpyrazol-1-yl)-[7-[(3-morpholin-4-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone;(4-methylpyrazol-1-yl)-[7-[(3-pyrrolidin-1-ylphenyl)methyl]-2,7-diazaspiro[4.4]nonan-2-yl]methanone |
| SMILES | COc1ccc(CN2CCC3(CCN(C(=O)n4cc(C)cn4)C3)C2)cc1.COc1cccc(CN2CCC3(CCN(C(=O)n4cc(C)cn4)C3)C2)c1.Cc1ccc(CN2CCC3(CCN(C(=O)n4cc(C)cn4)C3)C2)cc1.Cc1cccc(CN2CCC3(CCN(C(=O)n4cc(C)cn4)C3)C2)c1.Cc1cccc(CN2CCC3(CCN(C(=O)n4cc(C)cn4)C3)C2)c1.Cc1cnn(C(=O)N2CCC3(CCN(Cc4cccc(Cl)c4)C3)C2)c1.Cc1cnn(C(=O)N2CCC3(CCN(Cc4cccc(F)c4)C3)C2)c1.Cc1cnn(C(=O)N2CCC3(CCN(Cc4cccc(N5CCCC5)c4)C3)C2)c1.Cc1cnn(C(=O)N2CCC3(CCN(Cc4cccc(N5CCOCC5)c4)C3)C2)c1.Cc1cnn(C(=O)N2CCC3(CCN(Cc4ccccc4Cl)C3)C2)c1 |
| InChI | InChI=1S/C23H31N5O2.C23H31N5O.2C20H26N4O2.3C20H26N4O.2C19H23ClN4O.C19H23FN4O/c1-19-14-24-28(15-19)22(29)27-8-6-23(18-27)5-7-25(17-23)16-20-3-2-4-21(13-20)26-9-11-30-12-10-26;1-19-14-24-28(15-19)22(29)27-12-8-23(18-27)7-11-25(17-23)16-20-5-4-6-21(13-20)26-9-2-3-10-26;1-16-11-21-24(12-16)19(25)23-10-8-20(15-23)7-9-22(14-20)13-17-3-5-18(26-2)6-4-17;1-16-11-21-24(12-16)19(25)23-9-7-20(15-23)6-8-22(14-20)13-17-4-3-5-18(10-17)26-2;1-16-3-5-18(6-4-16)13-22-9-7-20(14-22)8-10-23(15-20)19(25)24-12-17(2)11-21-24;2*1-16-4-3-5-18(10-16)13-22-8-6-20(14-22)7-9-23(15-20)19(25)24-12-17(2)11-21-24;1-15-10-21-24(11-15)18(25)23-8-6-19(14-23)5-7-22(13-19)12-16-3-2-4-17(20)9-16;1-15-10-21-24(11-15)18(25)23-9-7-19(14-23)6-8-22(13-19)12-16-4-2-3-5-17(16)20;1-15-10-21-24(11-15)18(25)23-8-6-19(14-23)5-7-22(13-19)12-16-3-2-4-17(20)9-16/h2-4,13-15H,5-12,16-18H2,1H3;4-6,13-15H,2-3,7-12,16-18H2,1H3;3-6,11-12H,7-10,13-15H2,1-2H3;3-5,10-12H,6-9,13-15H2,1-2H3;3-6,11-12H,7-10,13-15H2,1-2H3;2*3-5,10-12H,6-9,13-15H2,1-2H3;2-4,9-11H,5-8,12-14H2,1H3;2-5,10-11H,6-9,12-14H2,1H3;2-4,9-11H,5-8,12-14H2,1H3 |
| InChIKey | MDHNMLYXJHBNNX-UHFFFAOYSA-N |
| XLogP | 30.40 |
| TPSA | 447.87 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 45 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 261 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3587.51 |
| LogP ≤ 5 | 30.40 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 45 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159533540 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.